AAV: An Overview of Unanswered Questions

Human Gene Therapy

Volumn 28, Issue 4, 2017, Pages 308-313

  Berns, Kenneth I ^a   Muzyczka, Nicholas ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

AAV cell interactions; AAV immunity; AAV persistence; AAV toxicity

Indexed keywords

ADENO ASSOCIATED VIRUS VECTOR;

ACUTE TOXICITY; ADENO ASSOCIATED VIRUS; CLINICAL TRIAL (TOPIC); HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PERSISTENT INFECTION; REVIEW; VIRAL GENE THERAPY; VIRUS CELL INTERACTION; VIRUS IMMUNITY; DEPENDOPARVOVIRUS; GENE THERAPY; GENE VECTOR; GENETICS; PROCEDURES;

DEPENDOVIRUS; GENETIC THERAPY; GENETIC VECTORS; HUMANS;

EID: 85018490014     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2017.048     Document Type: Review

References (57)

1. Kay M, Valdamanis P. Future of rAAV gene therapy: platform for RNAi, gene editing and beyond. Hum Gen Ther 2017;28:361-372.
2. Bryant LM, Christopher DM, Giles AR, et al. Lessons learned from the clinical development and market authorization of Glybera. Hum Gene Ther Clin Dev 2013;24:55-64.
3. McLaughlin SK, Collis P, Hermonat PL, Muzyczka N. Adeno-associated virus general transduction vectors: analysis of proviral structures. J Virol 1988;62:1963-1973.
4. Samulski RJ, Berns KI, Tan M, Muzyczka N. Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc Natl Acad Sci U S A 1982;79:2077-2081.
5. Hermonat PL, Muzyczka N. Use of adenoassociated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci U S A 1984;81:6466-6470.
6. Kotin R, Snyder R. Manufacturing clinical grade recombinant adeno-associated virus using invertebrate cell lines. Hum Gen Ther 2017;28:350-360.
7. Blacklow NR, Hoggan MD, Sereno MS, et al. A seroepidemiologic study of adenovirus-associated virus infection in infants and children. Am J Epidemiol 1971;94:359-366.
8. Chen CL, Jensen RL, Schnepp BC, et al. Molecular characterization of adeno-associated viruses infecting children. J Virol 2005;79:14781-14792.
9. Ertl H, High K. The impact of AAV capsid-specific T cell responses on design and outcome of clinical gene transfer trials with recombinant AAV vectors. Hum Gen Ther 2017;28:328-337.
10. Gernoux, G, Wilson, JM, Mueller, C. Regulatory and exhausted T cell responses to AAV capsid. Hum Gene Ther 2017 Mar 21. DOI: 10.1089/hum.2017.022 [Epub ahead of print].
11. Brister JR, Muzyczka N. Mechanism of Repmediated adeno-associated virus origin nicking. J Virol 2000;74:7762-7771.
12. Chiorini JA, Afione S, Kotin RM. Adenoassociated virus (AAV) type 5 Rep protein cleaves a unique terminal resolution site compared with other AAV serotypes. J Virol 1999;73:4293-4298.
13. Tseng YS, Gurda BL, Chipman P, et al. Adenoassociated virus serotype 1 (AAV1)-and AAV5-antibody complex structures reveal evolutionary commonalities in parvovirus antigenic reactivity. J Virol 2015;89:1794-1808.
14. Farkas SL, Zadori Z, Benko M, et al. A parvovirus isolated from royal python (Python regius) is a member of the genus Dependovirus. J Gen Virol 2004;85(Pt 3):555-561.
15. Salganik M, Venkatakrishnan B, Bennett A, et al. Evidence for pH-dependent protease activity in the adeno-associated virus capsid. J Virol 2012; 86:11877-11885.
16. Aydemir F, Salganik M, Resztak J, et al. Mutants at the 2-fold interface of adeno-associated virus type 2 (AAV2) structural proteins suggest a role in viral transcription for AAV capsids. J Virol 2016; 90:7196-7204.
17. Afione SA, Conrad CK, Kearns WG, et al. In vivo model of adeno-associated virus vector persistence and rescue. J Virol 1996;70:3235-3241.
18. Nakai H, Yant SR, Storm TA, et al. Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo. J Virol 2001;75: 6969-6976.
19. Xiao X, Xiao W, Li J, et al. A novel 165-base-pair terminal repeat sequence is the sole cis requirement for the adeno-associated virus life cycle. J Virol 1997;71:941-948.
20. Schnepp BC, Jensen RL, Clark KR, et al. Infectious molecular clones of adeno-associated virus isolated directly from human tissues. J Virol 2009;83: 1456-1464.
21. Kotin RM, Linden RM, Berns KI. Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J 1992; 11:5071-5078.
22. Daya S, Cortez N, Berns KI. Adeno-associated virus site-specific integration is mediated by proteins of the nonhomologous end-joining pathway. J Virol 2009;83:11655-11664.
23. Mehrle S, Rohde V, Schlehofer JR. Evidence of chromosomal integration of AAV DNA in human testis tissue. Virus Genes 2004;28:61-69.
24. Huser D, Khalid D, Lutter T, et al. High prevalence of infectious adeno-associated virus (AAV) in human peripheral blood mononuclear cells indicative of T lymphocytes as sites of AAV persistence. J Virol 2017;91.
25. Grossman Z, Mendelson E, Brok-Simoni F, et al. Detection of adeno-associated virus type 2 in human peripheral blood cells. J Gen Virol 1992; 73(Pt 4):961-966.
26. Friedman-Einat M, Grossman Z, Mileguir F, et al. Detection of adeno-associated virus type 2 sequences in the human genital tract. J Clin Microbiol 1997;35:71-78.
27. Tobiasch E, Rabreau M, Geletneky K, et al. Detection of adeno-associated virus DNA in human genital tissue and in material from spontaneous abortion. J Med Virol 1994;44:215-222.
28. Kessler PD, Podsakoff GM, Chen X, et al. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci U S A 1996;93:14082-14087.
29. Xiao X, Li J, Samulski RJ. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol 1996;70:8098-8108.
30. Lusby E, Fife KH, Berns KI. Nucleotide sequence of the inverted terminal repetition in adenoassociated virus DNA. J Virol 1980;34:402-409.
31. Spear IS, Fife KH, Hauswirth WW, et al. Evidence for two nucleotide sequence orientations within the terminal repetition of adeno-associated virus DNA. J Virol 1977;24:627-634.
32. Gottlieb J, Muzyczka N. Substrate specificity of HeLa endonuclease R. A G-specific mammalian endonuclease. J Biol Chem 1990;265:10842-10850.
33. Flotte TR, Afione SA, Solow R, et al. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J Biol Chem 1993;268:3781-3790.
34. McCarty DM, Christensen M, Muzyczka N. Sequences required for coordinate induction of adeno-associated virus p19 and p40 promoters by Rep protein. J Virol 1991;65:2936-2945.
35. Haberman RP, McCown TJ, Samulski RJ. Novel transcriptional regulatory signals in the adenoassociated virus terminal repeat A/D junction element. J Virol 2000;74:8732-8739.
36. Cathomen T, Stracker TH, Gilbert LB, et al. A genetic screen identifies a cellular regulator of adeno-associated virus. Proc Natl Acad Sci U S A 2001;98:14991-14996.
37. Ling C, Wang Y, Lu Y, et al. Enhanced transgene expression from recombinant single-stranded D-sequence-substituted adeno-associated virus vectors in human cell lines in vitro and in murine hepatocytes in vivo. J Virol 2015;89:952-961.
38. Chandler RJ, Sands M, Vendeiti CP. Recombinant adeno-associated viral integration and genotoxicity: insights from animal models. Hum Gene Ther 2017 Mar 15. DOI:10.1089/hum.2017.009 [Epub ahead of print].
39. Srivastava A, Carter B. AAV infection: protection from cancer. Hum Gene Ther 2017;28:323-327.
40. Grossman Z, Berns KI, Winocour E. Structure of simian virus 40-adeno-associated virus recombinant genomes. J Virol 1985;56:457-465.
41. Nault JC, Datta S, Imbeaud S, et al. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas. Nat Genet 2015;47:1187-1193.
42. Ogston P, Raj K, Beard P. Productive replication of adeno-associated virus can occur in human papillomavirus type 16 (HPV-16) episome-containing keratinocytes and is augmented by the HPV-16 E2 protein. J Virol 2000;74:3494-3504.
43. Hermonat PL. Adeno-associated virus inhibits human papillomavirus type 16: a viral interaction implicated in cervical cancer. Cancer Res 1994; 54:2278-2281.
44. Saudan P, Vlach J, Beard P. Inhibition of S-phase progression by adeno-associated virus Rep78 protein is mediated by hypophosphorylated pRb. EMBO J 2000;19:4351-4361.
45. Raj K, Ogston P, Beard P. Virus-mediated killing of cells that lack p53 activity. Nature 2001;412:914-917.
46. Malhomme O, Dutheil N, Rabreau M, et al. Human genital tissues containing DNA of adeno-associated virus lack DNA sequences of the helper viruses adenovirus, herpes simplex virus or cytomegalovirus but frequently contain human papillomavirus DNA. J Gen Virol 1997;78(Pt 8):1957-1962.
47. Ulusoy A, Sahin G, Bjorklund T, et al. Dose optimization for long-term rAAV-mediated RNA interference in the nigrostriatal projection neurons. Mol Ther 2009;17:1574-1584.
48. Hirsch ML, Fagan BM, Dumitru R. Viral singlestranded DNA induces p53-dependent apoptosis in human embryonic stem cells. PLoS One 2011; 6:e27520.
49. Becerra SP, Rose JA, Hardy M, et al. Direct mapping of adeno-associated virus capsid proteins B and C: a possible ACG initiation codon. Proc Natl Acad Sci U S A 1985;82:7919-7923.
50. Sonntag F, Schmidt K, Kleinschmidt JA. A viral assembly factor promotes AAV2 capsid formation in the nucleolus. Proc Natl Acad Sci U S A 2010;107:10220-10225.
51. Cao M, You H, Hermonat PL. The X gene of adeno-associated virus 2 (AAV2) is involved in viral DNA replication. PLOS One 2014;9:e104596.
52. Girod A, Wobus CE, Zadori Z, et al. The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity. J Gen Virol 2002;83(Pt 5):973-978.
53. Banez-Coronel M, Ayhan F, Tarabochia AD, et al. RAN translation in Huntington disease. Neuron 2015;88:667-677.
54. Stutika C, Gogol-Doring A, Botschen L, et al. A comprehensive RNA sequencing analysis of the adeno-associated virus (AAV) type 2 transcriptome reveals novel AAV transcripts, spice variants, and derived proteins. J Virol 2016;90: 1278-1289.
55. Stutika C, Mietzsch M, Gogol-Doring A, et al. Comprehensive small RNA-seq of adeno-associated virus (AAV)-infected human cells detects patterns of novel, non-coding AAV RNAs in the absence of cellular miRNA regulation. PLoS One 2016;11: e0161454.
56. Satkunanathan S, Wheeler J, Thorpe R, et al. Establishment of a novel cell line for the enhanced production of recombinant adeno-associated virus vectors for gene therapy. Hum Gene Ther 2014;25: 929-941.
57. Dong B, Duan X, Chow HY, et al. Proteomics analysis of co-purifying cellular proteins associated with rAAV vectors. PLoS One 2014;9:e86453.